enreach glp-1 Refills Launches Clinician-Led & Telehealth Platform Evernorth launches EnreachRx with Walgreens

Description

Much anticipated Phase II results in obesity for Amgens GLP-1 agonist/GIP antagonist showed up to 20% weight loss, but without detailed data the drugs competitiveness is hard to ascertain.

GLP-1 therapy in San Francisco delivered through individualized, physician-supervised programs focused on overall wellness and patient-centered care.

ShedRx provides virtual GLP-1 care with injections, drops, lozenges, brand-name options, and home delivery.

Our private label GLP-1 Booster formula is strategically developed to allow partners to enter this high-growth category quickly, professionally, and with a clinically positioned product that resonates with modern weight-management consumers